HLAG anticorps (N-Term)
Aperçu rapide pour HLAG anticorps (N-Term) (ABIN2207474)
Antigène
Voir toutes HLAG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- QRTPKIQVYS RHP-C
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- b2-Microglobulin (b2M)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- Peptide with sequence QRTPKIQVYSRHP-C, from the N-terminal domain of the protein sequence (NP_004039.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in Tris saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
-
Autre désignation
- b2-Microglobulin
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Antigène
-